Regeneron Pharmaceuticals (REGN) Enterprise Value Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.84% |
| Dec 31, 2025 | 4.52% |
| Sep 30, 2025 | 13.81% |
| Jun 30, 2025 | 23.85% |
| Mar 31, 2025 | 20.63% |
| Dec 31, 2024 | 16.90% |
| Sep 30, 2024 | 1.18% |
| Jun 30, 2024 | -9.87% |
| Mar 31, 2024 | -17.41% |
| Dec 31, 2023 | -40.07% |
| Sep 30, 2023 | -41.19% |
| Jun 30, 2023 | -17.99% |
| Mar 31, 2023 | -27.08% |
| Dec 31, 2022 | -35.96% |
| Sep 30, 2022 | -21.32% |
| Jun 30, 2022 | -93.47% |
| Mar 31, 2022 | -101.23% |
| Dec 31, 2021 | -58.76% |
| Sep 30, 2021 | -91.27% |
| Jun 30, 2021 | -24.38% |
| Mar 31, 2021 | 12.48% |
| Dec 31, 2020 | -11.60% |
| Sep 30, 2020 | -5.14% |
| Jun 30, 2020 | -17.77% |
| Mar 31, 2020 | -23.85% |
| Dec 31, 2019 | -14.39% |
| Sep 30, 2019 | -31.28% |
| Jun 30, 2019 | -58.58% |
| Mar 31, 2019 | -98.92% |
| Dec 31, 2018 | -99.35% |
| Sep 30, 2018 | -58.97% |
| Jun 30, 2018 | -32.79% |
| Mar 31, 2018 | -24.32% |
| Dec 31, 2017 | -35.70% |
| Sep 30, 2017 | 2.09% |
| Jun 30, 2017 | -82.03% |
| Mar 31, 2017 | -53.92% |
| Dec 31, 2016 | 0.63% |
| Sep 30, 2016 | -57.25% |
| Jun 30, 2016 | -15.27% |
| Mar 31, 2016 | -14.42% |
| Dec 31, 2015 | -16.07% |
| Sep 30, 2015 | 14.06% |
| Jun 30, 2015 | 26.03% |
| Mar 31, 2015 | -14.51% |
| Dec 31, 2014 | -29.76% |
| Sep 30, 2014 | -134.03% |
| Jun 30, 2014 | -51.98% |
| Mar 31, 2014 | -110.63% |
| Dec 31, 2013 | -125.25% |
| Sep 30, 2013 | -69.61% |
| Jun 30, 2013 | -78.56% |
| Mar 31, 2013 | 28.82% |
| Dec 31, 2012 | 41.53% |
| Sep 30, 2012 | -6.95% |
| Jun 30, 2012 | 2.80% |
| Mar 31, 2012 | -90.91% |
| Dec 31, 2011 | -111.31% |
| Sep 30, 2011 | 48.75% |
| Jun 30, 2011 | -1.09% |
| Mar 31, 2011 | -93.03% |
| Dec 31, 2010 | 26.94% |
| Sep 30, 2010 | -91.38% |
| Jun 30, 2010 | -12.85% |